Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.
Mol Cancer. 2023 Feb 4;22(1):25. doi: 10.1186/s12943-023-01729-7.
Mol Cancer. 2023.
PMID: 36739413
Free PMC article.